Skip to main content
SpringerLink
Log in

New Uses for Allopurinol

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Elion GB. The quest for a cure. Ann Rev Pharmacol Toxicol 1993; 33: 1–23

    Article  CAS  Google Scholar 

  2. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76: 47–56

    Article  PubMed  CAS  Google Scholar 

  3. Day RO, Miners JO, Birkett DJ, et al. Relationship between plasma oxypurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol. Br J Clin Pharmacol 1988; 26: 429–34

    Article  PubMed  CAS  Google Scholar 

  4. Birkett DJ, Miners J, Day RO. 1-Methylxanthine derived from theophylline as an in vivo probe of allopurinol effect. Br J Clin Pharmacol 1991; 32: 238–41

    Article  PubMed  CAS  Google Scholar 

  5. Day RO, Miners JO, Birkett DJ, et al. Allopurinol dosage selection: relationships between dose and plasma oxypurinol and urate concentrations and urinary urate excretion. Br J Clin Pharmacol 1988; 26: 423–8

    Article  PubMed  CAS  Google Scholar 

  6. Gibson T, Simmonds HA, Rogers AV, et al. Gout with apparent resistance to allopurinol. Ann Rheum Dis 1983; 42: 93–4

    Article  Google Scholar 

  7. Kott T, Day R, Brooks PM. Colchicine or nonsteroidal anti-inflammatory drug therapy for prophylaxis against gout during commencement of allopurinol therapy. Med J Aust 1993; 159: 162–4

    Google Scholar 

  8. Bellamy N, Brooks PM, Emmerson BT, et al. A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis in New South Wales and Queensland. Med J Aust 1989; 151: 531–7

    PubMed  CAS  Google Scholar 

  9. Faragher RI, Caelli DJ. Gout and hyperuricemia. Aust Fam Physician 1987; 16: 843–4

    PubMed  CAS  Google Scholar 

  10. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 1987; 46: 2402–6

    PubMed  CAS  Google Scholar 

  11. Reilly PM, Schiller HJ, Bulkley GB. Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 1991; 161: 488–503

    Article  PubMed  CAS  Google Scholar 

  12. Biemond P, Swaak AJG, Biendorff CM, et al. Superoxide-de-pendent and independent mechanisms of iron mobilization by xanthine oxidase. Biochem J 1986; 239: 169–73

    PubMed  CAS  Google Scholar 

  13. Johnson WD, Kayser KL, Brenowitz JB, et al. A randomised controlled trial of allopurinol in coronary bypass surgery. Am Heart J 1991; 121: 20–4

    Article  PubMed  CAS  Google Scholar 

  14. Rashid MA, William-Olsson G. Influence of allopurinol on cardiac complications in open heart operations. Ann Thorac Surg 1991; 52: 127–30

    Article  PubMed  CAS  Google Scholar 

  15. Tabayashi K, Suzuki Y, Nagamine S, et al. A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Car-diovasc Surg 1991; 101: 713–8

    CAS  Google Scholar 

  16. Coghlan JG, Flitter WD, Clutton SM, et al. Allopurinol pretreat-ment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1994; 107: 248–56

    PubMed  CAS  Google Scholar 

  17. Beizer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation 1988; 45: 673–6

    Google Scholar 

  18. Ploeg RJ. Kidney preservation with the UW and Euro-Collins solutions. Transplantation 1990; 49: 281–4

    Article  PubMed  CAS  Google Scholar 

  19. Olthoff KM, Millis JM, Imagawa DK, et al. Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts. Transplantation 1990; 49: 284–90

    Article  PubMed  CAS  Google Scholar 

  20. Salim AS. Role of oxygen-derived free radical scavengers in the treatment of recurrent pain produced by chronic pancreatitis. Arch Surg 1991; 126: 1109–14

    Article  PubMed  CAS  Google Scholar 

  21. Salim AS. The relationship between Helicobacter pylori and oxygen-derived free radicals in the mechanism of duodenal ulceration. Intern Med 1993; 32: 359–64

    Article  PubMed  CAS  Google Scholar 

  22. Salim AS. A new approach the treatment of nonsteroidal antiinflammatory drug induced gastric bleeding by free radical scavengers. Surg Gynecol Obstet 1993; 176: 484–90

    PubMed  CAS  Google Scholar 

  23. Marr JJ. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med 1991; 118: 111–9

    PubMed  CAS  Google Scholar 

  24. Martinez S and Marr JJ. Allopurinol in the treatment of American cutaneous leishmaniasis. N Eng J Med 1992; 326: 741–4

    Article  CAS  Google Scholar 

  25. Gallerano RH, Marr JJ, Sosa RR. Therapeutic efficacy of allopurinol in patients with Chagas’ disease. Am J Trop Med Hyg 1990; 43: 159–66

    PubMed  CAS  Google Scholar 

  26. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Eng J Med 1986; 315: 1386–9

    Article  CAS  Google Scholar 

  27. Zagnoni PG, Bianchi A, Zolo P et al. Allopurinol as an add-on therapy in refractory epilepsy — a double-blind placebo-controlled randomised study. Epilepsia 1994; 35: 107–12

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital, Victoria St, Darlinghurst, New South Wales, NSW 2010, Australia

    Richard O. Day, Mark Hicks & Garry G. Graham

  2. School of Physiology & Pharmacology, University of New South Wales, Randwick, New South Wales, Australia

    Richard O. Day, Mark Hicks & Garry G. Graham

  3. Department of Clinical Pharmacology, Flinders University, Bedford Park, South Australia, Australia

    Donald J. Birkett & John O. Miners

  4. Department of Medicine, St Vincent’s Hospital Darlinghurst, New South Wales, Australia

    Peter M. Brooks

  5. School of Medicine, University of New South Wales, Randwick, New South Wales, Australia

    Peter M. Brooks

Authors
  1. Richard O. Day
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Donald J. Birkett
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Hicks
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John O. Miners
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Garry G. Graham
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter M. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Day, R.O., Birkett, D.J., Hicks, M. et al. New Uses for Allopurinol. Drugs 48, 339–344 (1994). https://doi.org/10.2165/00003495-199448030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199448030-00002

Keywords

Search

Navigation